Analysed XENCOR INC (XNCR:NASDAQ) News Sources
Bi/Multispecific Drugs in Oncology Analytical Tool Featuring Top Developers - Amgen, Hoffmann-La Roche, J&J, Xencor, Biocytogen - Unlocking New Precision, Immune Activation, and Therapeutic Potential
12-05-2026
yahoo.com
Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution
14-06-2026
yahoo.com
VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone
02-07-2026
yahoo.com
Xencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
17-07-2026
yahoo.com
Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter
29-07-2026
yahoo.com
What is the current price of XENCOR INC (XNCR:NASDAQ)?
The current price of XENCOR INC (XNCR:NASDAQ) is $20.21.
XENCOR INC (XNCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of XENCOR INC (XNCR:NASDAQ) since the previous trading day is $-1.28.
XENCOR INC (XNCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of XENCOR INC (XNCR:NASDAQ) since the previous trading day is -5.9563%.
What is the most recent average sentiment score for XENCOR INC (XNCR:NASDAQ)?
The most recent average sentiment score for XENCOR INC (XNCR:NASDAQ) is 47 out of 100.
What is the most recent average sentiment for XENCOR INC (XNCR:NASDAQ)?
The most recent sentiment for XENCOR INC (XNCR:NASDAQ) is .
SEC-8K** Filing Available For XENCOR INC (XNCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.